145 related articles for article (PubMed ID: 17635141)
1. Unravelling the mechanisms underpinning chemokine receptor activation and blockade by small molecules: a fine line between agonism and antagonism?
Wise E; Pease JE
Biochem Soc Trans; 2007 Aug; 35(Pt 4):755-9. PubMed ID: 17635141
[TBL] [Abstract][Full Text] [Related]
2. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
Lau EK; Allen S; Hsu AR; Handel TM
Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866
[TBL] [Abstract][Full Text] [Related]
3. Chapter 8. Activation mechanisms of chemokine receptors.
Jensen PC; Rosenkilde MM
Methods Enzymol; 2009; 461():171-90. PubMed ID: 19480919
[TBL] [Abstract][Full Text] [Related]
4. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
Elsner J; Escher SE; Forssmann U
Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptors: attractive targets for drug discovery.
Godessart N
Ann N Y Acad Sci; 2005 Jun; 1051():647-57. PubMed ID: 16127005
[TBL] [Abstract][Full Text] [Related]
7. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
Carter PH; Tebben AJ
Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
[TBL] [Abstract][Full Text] [Related]
8. The clinical potential of chemokine receptor antagonists.
Ribeiro S; Horuk R
Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
[TBL] [Abstract][Full Text] [Related]
9. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
Haringman JJ; Oostendorp RL; Tak PP
Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
[TBL] [Abstract][Full Text] [Related]
10. Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugs.
Potzinger H; Geretti E; Brandner B; Wabitsch V; Piccinini AM; Rek A; Kungl AJ
Biochem Soc Trans; 2006 Jun; 34(Pt 3):435-7. PubMed ID: 16709180
[TBL] [Abstract][Full Text] [Related]
11. Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries.
Stroke IL; Cole AG; Simhadri S; Brescia MR; Desai M; Zhang JJ; Merritt JR; Appell KC; Henderson I; Webb ML
Biochem Biophys Res Commun; 2006 Oct; 349(1):221-8. PubMed ID: 16930533
[TBL] [Abstract][Full Text] [Related]
12. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
13. Chemokine blockers--therapeutics in the making?
Wells TN; Power CA; Shaw JP; Proudfoot AE
Trends Pharmacol Sci; 2006 Jan; 27(1):41-7. PubMed ID: 16310864
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
[TBL] [Abstract][Full Text] [Related]
15. Chemokines and their receptors in allergic disease.
Pease JE; Williams TJ
J Allergy Clin Immunol; 2006 Aug; 118(2):305-18; quiz 319-20. PubMed ID: 16890751
[TBL] [Abstract][Full Text] [Related]
16. Overview of the mechanisms regulating chemokine activity and availability.
Mortier A; Van Damme J; Proost P
Immunol Lett; 2012 Jul; 145(1-2):2-9. PubMed ID: 22698177
[TBL] [Abstract][Full Text] [Related]
17. International union of pharmacology. XXII. Nomenclature for chemokine receptors.
Murphy PM; Baggiolini M; Charo IF; Hébert CA; Horuk R; Matsushima K; Miller LH; Oppenheim JJ; Power CA
Pharmacol Rev; 2000 Mar; 52(1):145-76. PubMed ID: 10699158
[TBL] [Abstract][Full Text] [Related]
18. Regulation of chemokine activity by posttranslational modification.
Mortier A; Van Damme J; Proost P
Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
[TBL] [Abstract][Full Text] [Related]
19. Chemokine: receptor structure, interactions, and antagonism.
Allen SJ; Crown SE; Handel TM
Annu Rev Immunol; 2007; 25():787-820. PubMed ID: 17291188
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
